Shares in the company ended at $17.30 each on Thursday. The company sold 19 million shares for $15 each, according to a
The trading gives the New York-based company a market value of about $348 million, based on the outstanding shares listed in its filings.
LB Pharma’s IPO ended well oversubscribed, according to people familiar with the matter. It attracted anchor orders ...